title: Treatment persistency with rivastigmine and donepezil in a large state medicaid program.
authors.forename: Gurkirpal
authors.initials: G
authors.lastname: Singh
authors.forename: Simu K
authors.initials: SK
authors.lastname: Thomas
authors.forename: Steve
authors.initials: S
authors.lastname: Arcona
authors.forename: Vijayabharathi
authors.initials: V
authors.lastname: Lingala
authors.forename: Alka
authors.initials: A
authors.lastname: Mithal
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D000077265:Donepezil; D005260:Female; D006801:Humans; D007189:Indans / Q000627:therapeutic use*; D008297:Male; D010349:Patient Compliance; D048448:Phenylcarbamates / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D012107:Research Design; D000068836:Rivastigmine
chemical_list: D002800:Cholinesterase Inhibitors; D007189:Indans; D048448:Phenylcarbamates; D010880:Piperidines; D000077265:Donepezil; D000068836:Rivastigmine